相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes
Natalia Aptsiauri et al.
CLINICAL CANCER RESEARCH (2022)
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Per Anderson et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer
Meike Kohlruss et al.
BRITISH JOURNAL OF CANCER (2021)
Understanding the impact of immune-mediated selection on lung cancer evolution
Rachel Rosenthal et al.
BRITISH JOURNAL OF CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
MHC heterogeneity and response of metastases to immunotherapy
Ignacio Algarra et al.
CANCER AND METASTASIS REVIEWS (2021)
Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer
Maria Antonia Garrido et al.
CANCERS (2021)
Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
Zi-Ning Liu et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
Jian-Wei Xie et al.
FRONTIERS IN ONCOLOGY (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability
Meike Kohlruss et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma
Silvia Spoerl et al.
EUROPEAN JOURNAL OF CANCER (2018)
Determinants and clinical implications of chromosomal instability in cancer
Laurent Sansregret et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
Maria A. Garrido et al.
IMMUNOGENETICS (2018)
A microsatellite based multiplex PCR method for the detection of chromosomal instability in gastric cancer
Meike Kohlruss et al.
SCIENTIFIC REPORTS (2018)
A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer
L. Bauer et al.
ANNALS OF ONCOLOGY (2018)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas A Summary of 480 Cases
Karen Becker et al.
ANNALS OF SURGERY (2011)
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Isabel Maleno et al.
IMMUNOGENETICS (2011)
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible hard lesions
Federico Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Multiplex Manager 1.0: a cross-platform computer program that plans and optimizes multiplex PCR
Clare E. Holleley et al.
BIOTECHNIQUES (2009)
Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis
Simona Frigerio et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Loss of heterozygosity at 15q21.3 correlates with occurrence of metastases in head and neck cancer
Micaela Poetsch et al.
MODERN PATHOLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis
PA Gourraud et al.
TISSUE ANTIGENS (2004)
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
K Becker et al.
CANCER (2003)